BridgeBio Pharma Q4 Loss Widens, Revenue Rises -- Shares Up Pre-Bell-March 2024-www.financetom.com

BridgeBio Pharma Q4 Loss Widens, Revenue Rises -- Shares Up Pre-Bell

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BridgeBio Pharma Q4 Loss Widens, Revenue Rises -- Shares Up Pre-Bell

Feb 20, 2025 5:27 AM

07:58 AM EST, 02/20/2025 (MT Newswires) -- BridgeBio Pharma ( BBIO ) reported a Q4 net loss Thursday of $1.40 per diluted share, compared with a loss of $0.96 a year earlier.

Analysts polled by FactSet expected a loss of $1.13.

Revenue for the quarter ended Dec. 31 was $5.9 million, up from $1.74 million a year earlier.

Analysts surveyed by FactSet expected $3.1 million.

Shares were up more than 6% in recent premarket activity.

Previous page： Eyenovia Raises $5.1 Million From Public Offering Next page： Itron Insider Sold Shares Worth $425,210, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Eyenovia Raises $5.1 Million From Public Offering

Aug 29, 2024

11:54 AM EDT, 08/23/2024 (MT Newswires) -- Eyenovia ( EYEN ) said Friday that it closed its public offering of 12.85 million common shares at $0.40 apiece, raising about $5.1 million. The company said the net proceeds will be used to commercialize its postsurgical inflammation and pain treatment Mydcombi, advance its other product candidates, and for general working capital. Shares...

Itron Insider Sold Shares Worth $425,210, According to a Recent SEC Filing

Aug 29, 2024

11:47 AM EDT, 08/23/2024 (MT Newswires) -- Donald L. Reeves III, Senior Vice President, Outcomes, on August 22, 2024, sold 4,210 shares in Itron ( ITRI ) for $425,210. Following the Form 4 filing with the SEC, Reeves has control over a total of 16,269 shares of the company, with 16,269 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/780571/000112760224022827/xslF345X05/form4.xml Price: 102.00, Change:...

Intuit Fiscal Q4 Results Led by Small Business, Credit Karma, RBC Says

Aug 29, 2024

11:47 AM EDT, 08/23/2024 (MT Newswires) -- Intuit's (INTU) decent Q4 results were led by the Small Business and Self-Employed and the Credit Karma segments, but weakened by lower Consumer group performance, RBC Capital Markets said in a note Friday. The company reported fiscal Q4 non-GAAP earnings of $1.99 per diluted share on revenue of $3.18 billion. Analysts polled by...

Market Chatter: Meta Platforms Scraps Plans for Mixed-Reality Headset

Aug 29, 2024

11:54 AM EDT, 08/23/2024 (MT Newswires) -- Meta Platforms ( META ) scrapped plans for a high-end mixed-reality headset aimed at rivaling Apple's ( AAPL ) Vision Pro, The Information reported Friday, citing two Meta employees. This decision was communicated to employees in the Reality Labs division, instructing them to halt development on the device following a product review meeting...